New incident report
Incident Report Number: 2020-2330
Registrant Reference Number: 2019-US-030630
Registrant Name (Full Legal Name no abbreviations): The Hartz Mountain Corporation
Address: 400 Plaza Drive
City: Secaucus
Prov / State: New Jersey
Country: USA
Postal Code: 07094-3688
Domestic Animal
Country: UNITED STATES
Prov / State: GEORGIA
PMRA Registration No. PMRA Submission No. EPA Registration No. 2596-153
Product Name: Hartz UltraGuard Rid Flea and Tick Shampoo for Dogs
Liquid
Yes
Unknown
Site: Animal / Usage sur un animal domestique
Animal's Owner
Dog / Chien
Shih Tzu
1
Female
2
13
lbs
Skin
>24 hrs <=3 days / >24 h <=3 jours
>24 hrs <=3 days / >24 h <=3 jours
System
Persisted until death
No
No
Died
Treatment / Traitement
(eg. description of the frequency and severity of the symptoms
On 03-Nov-2019, a 2 year old, approximately 13 pound, intact, female, Shih Tzu dog, in unknown condition, with concomitant medical condition of fleas, was administered 1 application of Hartz UltraGuard Rid Flea and Tick Shampoo for Dogs (Phenothrin) via the topical route by the animal owner. On 05-Nov-2019, the dog suddenly developed weakness, vomiting, anorexia, ataxia and red eyes. The dog died while on her way to the veterinary facility. Though the pet owner was interested in pursuing a necropsy it is unknown if one was completed. No further information was received in this case.
Death
Assessment: The active ingredient in the product is present in low concentration and has a wide margin of safety in dogs. Delayed onset weakness, ataxia, vomiting, and conjunctivitis are not expected after use. Other causes should be considered in this case including flea bite anemia, underlying metabolic disease, and toxin exposure should be considered. No veterinary evaluation or diagnostics occurred making it difficult to assess this case further. The information contained in this report is based on self-reported statements provided to the registrant during telephone Interview(s). These self-reported descriptions of an incident have not been independently verified to be factually correct or complete descriptions of the incident. For that reason, information contained in this report does not and can not form the basis for a determination of whether the reported clinical effects are causally related to exposure to the product identified in the telephone interviews.